Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle
Conditions
Interventions
Intervention1: PUGAKHANDA AND
AYUSH PVK Gel: Pugakhanda 10 gm twice a day after food with milk for two months
AYUSH PVK Gel 3gm once daily applied intra vaginal for 15 days
Control Intervention1:
Sponsors
CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES
Eligibility
Inclusion criteria
Inclusion criteria: 1.Married woman of age between 18 to 40 years. 2.Presence of discharge per vaginum with or without itching/burning sensation /dyspareunia /foul smell for at least one month. 3.Patient agrees to refrain from use of douches oral or intra-vaginal antibiotics or antifungal agents or lubricants during the entire study period. 4.Patient willing and agrees to participate for three months and signs informed consent.
Exclusion criteria
Exclusion criteria: 1)Patient with Pelvic Inflammatory Disease (PID). 2)Patient with Abnormal Papanicolaou smear with Intra-epithelial or invasive cancer. 3)Patient with unexplained vaginal bleeding. 4)Abnormal findings on pelvic Sonography. 5)Patient with positive pregnancy test. 6)Patient with Fibromyoma, polyp ovarian tumour or cyst prolapse. 7)Systemic disease like heart disease tuberculosis and uncontrolled Diabetes Mellitus Hypertension and Severe anemia i.e Hemoglobin less than 7 gms 8)Use of antibiotics or local vaginal formulation within the previous month 9)Endocervical smear positive for gonococci, or positive VDRL HIV & HbsAg test 10)Patients who are currently participating in any other clinical trial or participated in past four weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the symptom-vaginal white discharge Foul smell vaginal itching vaginal burning sensation Burning Micturition Pain during intercourse Lower abdominal pain and any other associated symptomTimepoint: Baseline 15th 30th 45th 60th and 90th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in quality of life of the women in Swetapradara (Pathological leucorrhoea)Timepoint: Baseline 60th day and 90th day. | — |
Countries
India
Contacts
Public ContactDR PRASHANT SHINDE
Regional Ayurveda Research Institute For Mother and Child Health Nagpur
Outcome results
None listed